Literature DB >> 11904306

Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus.

Rajnish A Gupta, Raymond N DuBois.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11904306     DOI： 10.1093/jnci/94.6.406

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  13 in total

1.  Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.

Authors:  Panteleimon Kountourakis; Jaffer A Ajani; Marta Davila; Jeffrey H Lee; Manoop S Bhutani; Julie G Izzo
Journal:  Gastrointest Cancer Res       Date:  2012-03

2.  The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

Authors:  Luis J Herrera; Talal El-Hefnawy; Pierre E Queiroz de Oliveira; Siva Raja; Sydney Finkelstein; William Gooding; James D Luketich; Tony E Godfrey; Steven J Hughes
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

3.  Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.

Authors:  Linda M Liao; Thomas L Vaughan; Douglas A Corley; Michael B Cook; Alan G Casson; Farin Kamangar; Christian C Abnet; Harvey A Risch; Carol Giffen; Neal D Freedman; Wong-Ho Chow; Shahram Sadeghi; Nirmala Pandeya; David C Whiteman; Liam J Murray; Leslie Bernstein; Marilie D Gammon; Anna H Wu
Journal:  Gastroenterology       Date:  2011-11-19       Impact factor: 22.682

4.  Trifluoromethyl fluorocoxib a detects cyclooxygenase-2 expression in inflammatory tissues and human tumor xenografts.

Authors:  Md Jashim Uddin; Brenda C Crews; Imran Huda; Kebreab Ghebreselasie; Cristina K Daniel; Lawrence J Marnett
Journal:  ACS Med Chem Lett       Date:  2014-01-23       Impact factor: 4.345

5.  Mechano-transcription of COX-2 is a common response to lumen dilation of the rat gastrointestinal tract.

Authors:  Y-M Lin; F Li; X-Z Shi
Journal:  Neurogastroenterol Motil       Date:  2012-04-10       Impact factor: 3.598

6.  Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin.

Authors:  Fei Ye; Gui-Hong Zhang; Bao-Xiang Guan; Xiao-Chun Xu
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

7.  Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.

Authors:  Aaron P Thrift; Lesley A Anderson; Liam J Murray; Michael B Cook; Nicholas J Shaheen; Joel H Rubenstein; Hashem B El-Serag; Thomas L Vaughan; Jennifer L Schneider; David C Whiteman; Douglas A Corley
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

8.  Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.

Authors:  Arun George Paul; Bala Chandran; Neelam Sharma-Walia
Journal:  Transl Res       Date:  2013-03-20       Impact factor: 7.012

9.  Fluorocoxib A loaded nanoparticles enable targeted visualization of cyclooxygenase-2 in inflammation and cancer.

Authors:  Md Jashim Uddin; Thomas A Werfel; Brenda C Crews; Mukesh K Gupta; Taylor E Kavanaugh; Philip J Kingsley; Kelli Boyd; Lawrence J Marnett; Craig L Duvall
Journal:  Biomaterials       Date:  2016-03-21       Impact factor: 12.479

10.  Design, synthesis, and structure-activity relationship studies of fluorescent inhibitors of cycloxygenase-2 as targeted optical imaging agents.

Authors:  Md Jashim Uddin; Brenda C Crews; Kebreab Ghebreselasie; Lawrence J Marnett
Journal:  Bioconjug Chem       Date:  2013-03-28       Impact factor: 4.774
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.